Espero Biopharma is partnering with healthcare providers, physicians, and administrators to deliver superior alternatives for patients with cardiovascular disease. Our researchers have vast experience in cardiovascular disease, treatments and pharmacology. We work with physicians to identify areas of unmet need and explore the potential for treatment. Our current projects and programs include:
- Alternatives to warfarin and non-monitored therapy (NMT)
- Anti-coagulation in patients with kidney problems
- Anti-coagulation after heart valve surgery
- Management of cardiac arrhythmias
We invite you to review our Research section to learn about our recent and current clinical trials.